Phase transitions and structure analysis in wild-type, A30P, E46K, and A53T mutants of α-synuclein

被引：0
作者：
Mark A. Healey
Michael T. Woodside
Jack A. Tuszynski
机构：
[1] University of Alberta,Department of Physics
[2] National Research Council,National Institute for Nanotechnology
[3] University of Alberta,Department of Oncology
来源：
European Biophysics Journal | 2016年 / 45卷
关键词：
Intrinsically disordered protein; α-Synuclein; Parkinson’s disease; Monte Carlo simulations; Phase transitions; Mutations;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
α-Synuclein has been implicated in the development of neural plaques in Parkinson’s Disease and Lewy-Body Dementia. This paper reports on the structural phase change behavior exhibited over a relevant range of temperatures in canonical protein Monte Carlo simulations for wild-type α-synuclein and three of its familial variants. We performed and analyzed these simulations to determine residue occupancy variations above and below this phase transition. From this analysis, we found regions above the phase transition temperature that consistently exhibited increased propensity for formation of long-chain beta-sheets, suggesting a possible role in α-synuclein aggregation.
引用
收藏
页码：355 / 364
页数：9
相关论文
共 230 条
  • [1] Allison JR(2009)Determination of the free energy landscape of ɑ-synuclein using spin label nuclear magnetic resonance measurements J Am Chem Soc 131 18314-18326
  • [2] Varnai P(2011)Unfolded annealing molecular dynamics conformers for wild-type and disease-associated variatns of alpha-synuclein show no propensity for beta-sheet formation J Biophys Chem 2 123-133
  • [3] Dobson CM(2006)Protonless NMR experiments for sequence-specific assignment of backbone nuclei in unfolded proteins J Am Chem Soc 128 3918-3919
  • [4] Vendruscolo M(2005)Familial mutants of α-Synuclein with increased neurotoxicity have a destabilized conformation J Biol Chem 280 30649-30652
  • [5] Balesh DR(2006)Interaction of ɑ-synuclein with divalent metal ions reveals key differences: a link between structure, binding specificity and fibrillation enhancement J Am Chem Soc 128 9893-9901
  • [6] Ramjan Z(2012)α-synuclein misfolding and Parkinson’s disease Biochim Biophys Acta 1822 261-285
  • [7] Floriano WB(2001)Residual structure and dynamics in Parkinson’s disease-associated mutants of ɑ-synuclein J Biol Chem 276 45996-46003
  • [8] Bermel WB(2013)A Relationship between the aggregation rates of α-synuclein variants and the β-Sheet populations in their monomeric forms J Phys Chem B 117 10737-10741
  • [9] Bertini I(2007)Investigation of α-synuclein fibril structure by site-directed spin labelling J Biol Chem 282 24970-24979
  • [10] Felli I(2009)Structural characterization of ɑ-synuclein in an aggregation prone state Protein Sci 18 1840-1846
12345678910